Antihyperlipidemic effect of crocin isolated from the fructus of Gardenia jasminoides and its metabolite crocetin

被引:208
作者
Lee, IA
Lee, JH
Baek, NI
Kim, DH
机构
[1] Kyung Hee Univ, Coll Pharm, Seoul 130701, Kyunggi, South Korea
[2] Kyung Hee Univ, Grad Sch Biotechnol, Suwon 449701, South Korea
[3] Kyung Hee Univ, PMRC, Suwon 449701, South Korea
关键词
Gardeniae fructus; crocin; crocetin; pancreatic lipase; hypolipidemic activity;
D O I
10.1248/bpb.28.2106
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The pancreatic lipase inhibitors were isolated from the fructus of Gardenia jasminoides ELLIS, and their antihyperlipidemic activities were measured. Gardeniae fructus (GF) water extract inhibited pancreatic lipase activity. Crocetin and crocin were isolated from GF water extract as inhibitors of pancreatic lipase with an IC50 value of 2.1 and 2.6 mg/ml (triolein as a substrate). Crocin and crocetin significantly inhibited the increase of serum TG level in corn oil feeding-induced triglyceridemic mice, as well as that of serum triglyceride and total and LDL cholesterol levels in Triton WR-1339-induced hyperlipidemic mice. These compounds also showed hypolipidemic activity in hyperlipidemic mice induced by high cholesterol, high fat or high carbohydrate diets for 5 weeks. The results suggest that the hypolipidemic activity of GF and its component crocin may be due to the inhibition of pancreatic lipase and crocin, and its metabolite, crocetin, can improve hyperlipidemia.
引用
收藏
页码:2106 / 2110
页数:5
相关论文
共 19 条
  • [1] Crocin antagonizes ethanol inhibition of NMDA receptor-mediated responses in rat hippocampal neurons
    Abe, K
    Sugiura, M
    Shoyama, Y
    Saito, H
    [J]. BRAIN RESEARCH, 1998, 787 (01) : 132 - 138
  • [2] ALLAIN CC, 1974, CLIN CHEM, V20, P470
  • [3] Metabolism of 20(S)- and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities
    Bae, EA
    Han, MJ
    Choo, MK
    Park, SY
    Kim, DH
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2002, 25 (01) : 58 - 63
  • [4] Orlistat: its current status as an anti-obesity drug
    Ballinger, A
    Peikin, SR
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 440 (2-3) : 109 - 117
  • [5] LIPID DIGESTION AND ABSORPTION
    CAREY, MC
    SMALL, DM
    BLISS, CM
    [J]. ANNUAL REVIEW OF PHYSIOLOGY, 1983, 45 : 651 - 677
  • [6] 780 SE - NEW TYPE OF HYPOLIPEMIC AGENT - COMPARATIVE ASSAYS IN RATS
    DUHAULT, J
    BOULANGER, M
    BEREGI, L
    SICOT, N
    BOUVIER, F
    [J]. ATHEROSCLEROSIS, 1976, 23 (01) : 63 - 72
  • [7] HYPERLIPIDEMIA IN CORONARY HEART-DISEASE .2. GENETIC ANALYSIS OF LIPID-LEVELS IN 176 FAMILIES AND DELINEATION OF A NEW INHERITED DISORDER, COMBINED HYPERLIPIDEMIA
    GOLDSTEIN, JL
    SCHROTT, HG
    HAZZARD, WR
    BIRMAN, EL
    MOTULSKY, AG
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (07) : 1544 - 1568
  • [8] Hsu JD, 1999, ANTICANCER RES, V19, P4221
  • [9] PHARMACOLOGICAL INVESTIGATION OF BEZAFIBRATE, A HYPOLIPIDEMIC AGENT .1. EFFECTS OF BEZAFIBRATE ON NORMAL AND EXPERIMENTAL HYPERLIPIDEMIA IN RATS
    KUSAMA, H
    NISHIYAMA, M
    IKEDA, S
    [J]. FOLIA PHARMACOLOGICA JAPONICA, 1988, 92 (03) : 175 - 180
  • [10] Machida K, 2000, CHEM PHARM BULL, V48, P746